{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:00:52Z","timestamp":1787166052560,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100014054","name":"DNDi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de Minas Gerais"},{"DOI":"10.13039\/501100009730","name":"Universidade Federal de Ouro Preto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009730","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bcp.2018.01.005","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T12:44:45Z","timestamp":1515156285000},"page":"213-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: A pre-clinical study"],"prefix":"10.1016","volume":"148","author":[{"given":"Ana Lia","family":"Mazzeti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia de F.","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina R.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro F.S.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pollyanna A.F.","family":"Sp\u00f3sito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa C.F.","family":"Mosqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.L.","family":"Machado-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"Bahia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2018.01.005_b0005","unstructured":"WHO. Chagas disease, Fact sheet No. 340 \u2013 updated March 2017. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs340\/en\/; 2017 [accessed 30.06.17]."},{"issue":"1","key":"10.1016\/j.bcp.2018.01.005_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/S0074-02762009000900005","article-title":"Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy","volume":"104","author":"Moncayo","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"12","key":"10.1016\/j.bcp.2018.01.005_b0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.pt.2006.09.011","article-title":"The future of Chagas disease control","volume":"22","author":"Schofield","year":"2006","journal-title":"Trends Parasitol."},{"issue":"9","key":"10.1016\/j.bcp.2018.01.005_b0020","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1517\/13543784.2014.922952","article-title":"Therapeutical approaches under investigation for treatment of Chagas disease","volume":"23","author":"Bahia","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2018.01.005_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0074-02762002000100001","article-title":"A critical review on Chagas disease chemotherapy","volume":"97","author":"Coura","year":"2002","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"7","key":"10.1016\/j.bcp.2018.01.005_b0030","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1371\/journal.pntd.0000488","article-title":"Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Medecins Sans Fronti\u00e8res","volume":"3","author":"Yun","year":"2009","journal-title":"PLos Neg. Trop. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2018.01.005_b0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/S0074-02762010000200022","article-title":"In vitro and in vivo experimental models for drug screening and development for Chagas disease","volume":"105","author":"Romanha","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"3","key":"10.1016\/j.bcp.2018.01.005_b0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1586\/17512433.2014.909282","article-title":"Potential new clinical therapies for Chagas disease","volume":"7","author":"Bustamante","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.005_b0045","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease","volume":"81","author":"Filardi","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.bcp.2018.01.005_b0050","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.bcp.2018.01.005_b0055","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4269\/ajtmh.2012.11-0471","article-title":"In vitro and in vivo studies of the trypanocidal activity of four terpenoid derivatives against Trypanosoma cruzi","volume":"87","author":"Ram\u00edrez-Mac\u00edas","year":"2012","journal-title":"Am. J. Trop. Med. Hygn."},{"issue":"6","key":"10.1016\/j.bcp.2018.01.005_b0060","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00436-010-1780-7","article-title":"New method for quantification of Trypanosoma cruzi in animal's tissue in the chronic phase of experimental Chagas' disease","volume":"106","author":"Esperandim","year":"2010","journal-title":"Parasitol. Res"},{"issue":"10","key":"10.1016\/j.bcp.2018.01.005_b0065","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1128\/AAC.00104-09","article-title":"Experimental chemotherapy against Trypanosoma cruzi infection using ruthenium nitric oxide donors","volume":"53","author":"Silva","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.bcp.2018.01.005_b0070","doi-asserted-by":"crossref","first-page":"e22155","DOI":"10.1371\/journal.pone.0022155","article-title":"Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo","volume":"6","author":"Batista","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2018.01.005_b0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpddr.2015.12.001","article-title":"Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain","volume":"6","author":"Cevey","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"10","key":"10.1016\/j.bcp.2018.01.005_b0080","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1128\/AAC.00689-15","article-title":"Antitrypanosomal treatment with benznidazole is superior to posaconazole regimens in mouse models of chagas disease","volume":"59","author":"Khare","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2018.01.005_b0085","first-page":"389","article-title":"Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi","volume":"4","author":"Brener","year":"1962","journal-title":"Rev. Inst. Med. Trop."},{"issue":"11","key":"10.1016\/j.bcp.2018.01.005_b0090","doi-asserted-by":"crossref","first-page":"e1870","DOI":"10.1371\/journal.pntd.0001870","article-title":"Fexinidazole: a potential new drug candidate for Chagas disease","volume":"6","author":"Bahia","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.bcp.2018.01.005_b0095","doi-asserted-by":"crossref","first-page":"e0128707","DOI":"10.1371\/journal.pone.0128707","article-title":"Benznidazole\/itraconazole combination treatment enhances anti-trypanosoma cruzi activity in experimental Chagas disease","volume":"10","author":"Martins","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bcp.2018.01.005_b0100","first-page":"721","article-title":"Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types","volume":"63","author":"Andrade","year":"1985","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.bcp.2018.01.005_b0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.exppara.2007.08.016","article-title":"Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole","volume":"118","author":"Caldas","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bcp.2018.01.005_b0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-6851(03)00093-8","article-title":"Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR","volume":"129","author":"Cummings","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"issue":"10","key":"10.1016\/j.bcp.2018.01.005_b0115","first-page":"966","article-title":"Posaconazole versus benznidazole for chronic Chagas' disease","volume":"371","author":"Molina","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2018.01.005_b0120","unstructured":"Torrico F. Annual Meeting of the American Society of Tropical Medicine and Hygiene: E1224 \u2013 results of proof-of-concept clinical trial in patients with chronic indeterminate Chagas disease. Available from: http:\/\/www.dndi.org\/about-us\/our-people\/team\/354-media-centre\/press-releases\/1700-e1224."},{"key":"10.1016\/j.bcp.2018.01.005_b0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/infdis\/jit420","article-title":"New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice","volume":"209","author":"Bustamante","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2018.01.005_b0130","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/AAC.00745-15","article-title":"New Scheme of intermittent benznidazole administration in patients chronically infected with Trypanosoma cruzi: a pilot short-term follow-up study with adult patients","volume":"60","author":"\u00c1lvarez","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.bcp.2018.01.005_b0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0213-005X(02)72829-2","article-title":"Pharmacokinetic and pharmacodynamic concepts for an interpretative reading of the antibiogram","volume":"20","author":"Soriano","year":"2002","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.bcp.2018.01.005_b0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/AAC.47.1.223-230.2003","article-title":"Chemotherapy with benznidazole or itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes","volume":"47","author":"Toledo","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.bcp.2018.01.005_b0145","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1128\/AAC.04660-14","article-title":"Toxic profile of benznidazole in patients with chronic Chagas disease: risk factors and comparison of the product from two different manufacturers","volume":"59","author":"Molina","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2018.01.005_b0150","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/jac\/dks027","article-title":"Safety of benznidazole use in the treatment of chronic Chagas\u2019 disease","volume":"67","author":"Hasslocher-Moreno","year":"2012","journal-title":"J. Antimicrob Chemother."},{"issue":"5","key":"10.1016\/j.bcp.2018.01.005_b0155","doi-asserted-by":"crossref","first-page":"e2907","DOI":"10.1371\/journal.pntd.0002907","article-title":"Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults","volume":"8","author":"Altcheh","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bcp.2018.01.005_b0160","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/AAC.01401-12","article-title":"Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic Chagas disease","volume":"57","author":"Pinazo","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.bcp.2018.01.005_b0165","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1590\/0074-02760150401","article-title":"Pharmacocinetic and pharmacodynamic responses in adults patients with Chagas disease treated with as new formulation of benznidazole","volume":"111","author":"Fern\u00e1ndez","year":"2016","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"5","key":"10.1016\/j.bcp.2018.01.005_b0170","first-page":"600","article-title":"Administration of substances to laboratory animals: routes of administration and factors to consider","volume":"50","author":"Turner","year":"2011","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2018.01.005_b0175","first-page":"453","article-title":"The role of the diaphragm in lymphatic absorption from the peritoneal cavity","volume":"186","author":"Abu-Hijleh","year":"1995","journal-title":"J. Anat."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218300054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218300054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T06:46:51Z","timestamp":1655880411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218300054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":35,"alternative-id":["S0006295218300054"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.01.005","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time and dose-dependence evaluation of nitroheterocyclic drugs for improving efficacy following Trypanosoma cruzi infection: A pre-clinical study","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}